Search
Bruce Levine on UPenn's Center for Cellular Immunotherapies and his thoughts regarding FDA's recent CAR-T guidance
Dr. Levine highlights work being done at UPenn including a 3-day CAR with IL-18, a dual CAR targeting GBM
Feb 8, 2024
UPenn’s Bruce Levine discusses the progress of CAR-T at the 2023 CAR-TCR Summit
Dr. Levine talks about emerging technology trends that might improve CAR-T therapies on the six-year anniversary of the first approved CAR-T
Aug 30, 2023
Talking cell therapy with the co-inventor of CAR-T
UPenn's Bruce Levine catches us up on the latest in cell therapy at #ATW23.
Jan 18, 2023
.png){kind=logo}
